Next generation biofilm inhibitors for Pseudomonas aeruginosa: Synthesis and rational design approaches

Mahesh S Majik, Prakash T Parvatkar1

  • 1Bio-organic Chemistry Laboratory, CSIR-National Institute of Oceanography, Dona-Paula Goa 403 004, India. majikms@gmail.com.

Insights

Marine natural products offer promising small molecules to combat drug-resistant bacterial biofilms, particularly in Pseudomonas aeruginosa, a major cause of hospital-acquired infections.

Area of Science:

  • Microbiology
  • Medicinal Chemistry
  • Pharmacology

Background:

  • Bacterial biofilms contribute significantly to persistent and difficult-to-treat nosocomial infections, affecting 65-80% of microbial infections in developed nations.
  • The rise of multiple drug resistance in bacteria necessitates novel therapeutic strategies targeting biofilm formation and maintenance.
  • Pseudomonas aeruginosa, a prevalent cause of hospital-acquired infections, serves as a critical model organism for biofilm research.

Purpose of the Study:

  • To review the development of small molecules, particularly from marine natural products, that inhibit or disperse bacterial biofilms.
  • To highlight strategies for targeting Pseudomonas aeruginosa biofilms.
  • To discuss rational design, synthetic methodologies, and biological evaluations of these small molecules.

Main Methods:

  • Literature review focusing on marine natural products and their derivatives as biofilm inhibitors.
  • Analysis of studies detailing rational design and synthetic approaches for small molecule development.
  • Compilation of biological data on the efficacy of these compounds against Pseudomonas aeruginosa biofilms.

Main Results:

  • Marine natural products represent a rich source of novel chemical scaffolds with anti-biofilm activity.
  • Several small molecules have demonstrated significant potential in inhibiting or dispersing Pseudomonas aeruginosa biofilms.
  • Integrated approaches combining rational design, synthesis, and biological testing accelerate the discovery of effective anti-biofilm agents.

Conclusions:

  • Small molecules derived from marine natural products are valuable leads for developing new treatments against bacterial biofilms.
  • Targeting Pseudomonas aeruginosa biofilms with novel small molecules is crucial for managing nosocomial infections.
  • Further research into rational design and synthesis holds promise for advancing anti-biofilm therapies.

Related Concept Videos

Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
960
Biofilms01:29

Biofilms

Biofilms are complex communities of microorganisms encased in a self-produced extracellular polysaccharide matrix attached to surfaces. These microbial consortia can include single or multiple species, providing enhanced survival benefits by forming organized, multilayered structures.The formation of biofilms occurs through four key stages: attachment, colonization, development, and dispersal.During attachment, free-swimming planktonic cells adhere to a surface, often facilitated by...
2.1K
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
216
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These...
151